[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Nyxoah S A (NYXH)

Nyxoah S A (NYXH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Nyxoah S A RUE EDOUARD BELIN 12 MONT-SAINT-GUIBERT C9 1435 BEL

www.nyxoah.com Employees: 154 P: 321-022-2355

Sector:

Medical

Description:

Nyxoah SA is a medical technology company. It focused on the development and commercialization of solutions to treat Obstructive Sleep Apnea. Nyxoah SA is based in Belgium.

Key Statistics

Overview:

Market Capitalization, $K 126,361
Enterprise Value, $K 138,421
Shares Outstanding, K 38,761
Float, K 32,129
% Float 82.89%
Short Interest, K 323
Short Float 0.83%
Days to Cover 6.45
Short Volume Ratio 0.40
% of Insider Shareholders 17.11%
% of Institutional Shareholders 0.00%

Financials:

Annual Sales, $ 11,340 K
Annual Net Income, $ -101,920 K
Last Quarter Sales, $ 6,530 K
Last Quarter Net Income, $ -29,020 K
EBIT, $ -94,450 K
EBITDA, $ -89,380 K

Growth:

1-Year Return -47.42%
3-Year Return -58.99%
5-Year Return 0.00%
5-Year Revenue Growth 14,075.00%
5-Year Earnings Growth -246.75%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.68 on 03/19/26
Next Earnings Date 05/12/26 [AMC]
Earnings Per Share ttm -2.68
EPS Growth vs. Prev Qtr 8.11%
EPS Growth vs. Prev Year -38.78%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

NYXH Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -139.18%
Return-on-Assets % -79.53%
Profit Margin % -898.77%
Debt/Equity 0.83
Price/Sales 10.94
Price/Cash Flow N/A
Price/Book 2.23
Book Value/Share 1.43
Interest Coverage -6.73
60-Month Beta 1.56
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.